Citadel Advisors’s Lixte Biotechnology LIXT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-24,522
| Closed | -$29.7K | – | 6478 |
|
|
2025
Q1 | $29.7K | Buy |
+24,522
| New | +$29.7K | ﹤0.01% | 5514 |
|
|
2022
Q3 | – | Sell |
-3,006
| Closed | -$23K | – | 6354 |
|
|
2022
Q2 | $23K | Buy |
+3,006
| New | +$23K | ﹤0.01% | 5684 |
|
|
2021
Q3 | – | Sell |
-1,239
| Closed | -$38K | – | 6790 |
|
|
2021
Q2 | $38K | Sell |
1,239
-1,142
| -48% | -$35K | ﹤0.01% | 6256 |
|
|
2021
Q1 | $79K | Buy |
+2,381
| New | +$79K | ﹤0.01% | 5944 |
|